REDS study: Retrospective effectiveness study of dalbavancin and other standard of care of the same IV antibiotic class in patients with ABSSSI.

Theodossis Papavramidis,Ivan Gentile,Anna Maria Cattelan,Laura Magnasco,Pierluigi Viale,Daniela Francisci,Diamantis P Kofteridis,Giusy Tiseo,Evangelos J Giamarellos-Bourboulis,Filippo Lagi,Simone Mornese Pinna, Federico D'Amico, Lucia La Ferla,Periklis Panagopoulos,Gianni Gattuso,Nikolaos V Sipsas,Alessandro Ruggieri,Agnese Cattaneo, Luciana Corio,Alessandro Comandini, Patrizia Mascagni,Matteo Bassetti

International journal of antimicrobial agents（2023）

引用 1|浏览22

暂无评分

摘要

Although the analysis was only descriptive, it can be concluded that dalbavancin may enable a remarkable reduction in length of hospital stay, also confirming the clinical effectiveness and good safety profile demonstrated in clinical trials in a real-world setting.

查看译文

关键词

ABSSSI,Dalbavancin,Retrospective,Skin and skin-structure infections,Time to discharge

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要